This A5 leaflet provides a general overview of TB, including symptoms, transmission and risk factors. This leaflet is available to download as a print friendly version in the following languages: Arabic, Bengali, English, Farsi, Gujarati, Hindi, Nepali, Pashto, Punjabi, Somali, Tamil and Urdu
Version 3.0
Accessed: 24.11.2019
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...he HIV epidemic and the emergence of multidrug-resistant (MDR) and extensively drug resistant (XDR) tuberculosis. The urgent development of new tools that can improve the diagnosis, prevention and/or treatment of tuberculosis and other major mycobacterium diseases depends largely on the progress of basic and applied research. Faced with this situation, there is an urgent need for effective strategies and actions to permanently solve the problem of this endemic disease whose impact is too negative on people’s lives.
more
For more information on TB or to get a TB test, call your doctor or local health department www.cdc.gov/tb/links/tboffices.htm. For further information on TB visit: CDC Division of Tuberculosis Elimination Website at www.cdc.gov/tb.
Accessed November 2017
TB and HIV/AIDS
Accessed November 2017
Fact sheet -Updated November 2015